ARGENX SE is 20.6x more valuable than Relay Therapeutics, Inc. by market capitalization ($53.35 B vs $2.58 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | RLAY | ARGX |
|---|---|---|
| Market cap | $2.58 B | $53.35 B |
| US-listed rank | #1916 | #306 |
| Revenue (latest FY) | $15.36M | - |
| Net income (latest FY) | -$276.48M | - |
| Net margin | -1800.6% | - |
| SEC filings | 506 | 272 |
ARGENX SE is 20.6x more valuable than Relay Therapeutics, Inc. by market capitalization ($53.35 B vs $2.58 B).
Full pages: Relay Therapeutics, Inc. and ARGENX SE, or browse the full rankings.